How much do 68Ga-, 177Lu- and 131I-based radiopharmaceuticals contribute to the global radiation exposure of nuclear medicine staff?

Autor: L. Struelens, E. Aalbersberg, L. Beels, N. Cherbuin, Y. D’Asseler, F. De Monte, A. Lopez Medina, M. del Carmen Riveira Martin, W. Schoonjans, C. Terwinghe, S. Van den Block, F. Vanhavere, H. Zaidi, V. Schelfhout

Publikováno v: EJNMMI Physics, Vol 11, Iss 1, Pp 1-15 (2024)

Abstract Background The radiation exposure of nuclear medicine personnel, especially concerning extremity doses, has been a significant focus over the past two decades. This study addresses the evolving practice of NM, particularly with the rise of r

Externí odkaz: https://doaj.org/article/c05d00eebcfe4de582c9615eaa63693b

How much do ⁶⁸ Ga-, ¹⁷⁷ Lu- and ¹³¹ I-based radiopharmaceuticals contribute to the global radiation exposure of nuclear medicine staff?

Autor: Struelens L; Belgian Nuclear Research Center (SCK CEN), Nuclear Medical Applications, Mol, Belgium. lara.struelens@sckcen.be., Aalbersberg E; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands., Beels L; Nuclear Medicine Department, AZ Groeninge, Kortrijk, Belgium., Cherbuin N; Institute of Radiation Physics (IRA), Lausanne University Hospital, Lausanne, Switzerland., D'Asseler Y; Department of Diagnostic Sciences, University Hospital Ghent and Ghent University, Ghent, Belgium., De Monte F; Medical Physics Department, IRCCS, Veneto Institute of Oncology (IOV), Padua, Italy., Lopez Medina A; Medical Physics Department (SERGAS), Hospital do Meixoeiro, Vigo, Spain.; Instituto de Investigación Biomédica Galicia Sur, Vigo, Spain., Del Carmen Riveira Martin M; Medical Physics Department (SERGAS), Hospital do Meixoeiro, Vigo, Spain., Schoonjans W; Belgian Nuclear Research Center (SCK CEN), Nuclear Medical Applications, Mol, Belgium., Terwinghe C; Department of Nuclear Medicine, University Hospital Gasthuisberg, Leuven, Belgium., Van den Block S; Nuclear Medicine Department, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium., Vanhavere F; Belgian Nuclear Research Center (SCK CEN), Nuclear Medical Applications, Mol, Belgium., Zaidi H; Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, Geneva, Switzerland.; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Department of Nuclear Medicine, University of Southern Denmark, Odense, Denmark.; University Research and Innovation Center, Óbudabuda University, Budapest, Hungary., Schelfhout V; Department of Diagnostic Sciences, University Hospital Ghent and Ghent University, Ghent, Belgium.

Publikováno v: EJNMMI physics [EJNMMI Phys] 2024 Nov 14; Vol. 11 (1), pp. 95. Date of Electronic Publication: 2024 Nov 14.

A systematic review and meta-analysis on the radiation dose of computed tomography in hybrid nuclear medicine imaging.

Autor: Verfaillie G; Department of Human Structure and Repair, Ghent University, Ghent, Belgium. gwenny.verfaillie@ugent.be., Franck C; mVISION, Faculty of Medicine and Health Sciences, Antwerp University, Antwerp, Belgium., De Crop A; Department of Nuclear Medicine, AZ Delta, Roeselare, Belgium.; Department of Radiology, AZ Delta, Roeselare, Belgium., Beels L; Department of Nuclear Medicine, AZ Groeninge, Kortrijk, Belgium., D'Asseler Y; Department of Nuclear Medicine, Ghent University Hospital, Ghent, Belgium.; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium., Bacher K; Department of Human Structure and Repair, Ghent University, Ghent, Belgium.

Publikováno v: EJNMMI physics [EJNMMI Phys] 2023 May 25; Vol. 10 (1), pp. 32. Date of Electronic Publication: 2023 May 25.

Quantification of 18F-fluorodeoxyglucose uptake to detect residual nodal disease in locally advanced head and neck squamous cell carcinoma after chemoradiotherapy: results from the ECLYPS study.

Autor: Helsen N; Department of Nuclear Medicine, Antwerp University Hospital, Edegem, Belgium. nilshelsen@hotmail.com.; Faculty of Medicine and Health Sciences, University of Antwerp, wilrijk, 2650, Antwerp, Belgium. nilshelsen@hotmail.com., Van den Wyngaert T; Department of Nuclear Medicine, Antwerp University Hospital, Edegem, Belgium.; Faculty of Medicine and Health Sciences, University of Antwerp, wilrijk, 2650, Antwerp, Belgium., Carp L; Department of Nuclear Medicine, Antwerp University Hospital, Edegem, Belgium.; Faculty of Medicine and Health Sciences, University of Antwerp, wilrijk, 2650, Antwerp, Belgium., De Bree R; Amsterdam UMC, Departments of Otolaryngology-Head and Neck Surgery, and Radiology & Nuclear Medicine, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.; Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., VanderVeken OM; Faculty of Medicine and Health Sciences, University of Antwerp, wilrijk, 2650, Antwerp, Belgium.; Department Otorhinolaryngology, and Head & Neck Surgery, Antwerp University Hospital, Edegem, Belgium., De Geeter F; Department of Nuclear Medicine, AZ Sint Jan, Brugge, Belgium., Maes A; Department of Nuclear Medicine, AZ Groeninge, Kortrijk, Belgium., Cambier JP; Department of Nuclear Medicine, Jessa Hospital, Hasselt, Belgium., Spaepen K; Department of Nuclear Medicine, Sint Augustinus, Wilrijk, Belgium., Martens M; Department of radiotherapy, AZ Turnhout, Turnhout, Belgium., Hakim S; Amsterdam UMC, Departments of Otolaryngology-Head and Neck Surgery, and Radiology & Nuclear Medicine, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Beels L; Department of Nuclear Medicine, AZ Groeninge, Kortrijk, Belgium., Hoekstra OS; Amsterdam UMC, Departments of Otolaryngology-Head and Neck Surgery, and Radiology & Nuclear Medicine, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Van den Weyngaert D; Department of radiotherapy, ZNA Middelheim, Antwerp, Belgium., Stroobants S; Department of Nuclear Medicine, Antwerp University Hospital, Edegem, Belgium.; Faculty of Medicine and Health Sciences, University of Antwerp, wilrijk, 2650, Antwerp, Belgium., Van Laer C, Specenier P, Maes A, Debruyne P, Hutsebaut I, Van Dinter J, Homans F, Goethals L, Lenssen O, Deben K

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2020 May; Vol. 47 (5), pp. 1075-1082. Date of Electronic Publication: 2020 Feb 10.

Impact of PET reconstruction protocols on quantification of lesions that fulfil the PERCIST lesion inclusion criteria.

Autor: Devriese J; Department of Public Health and Primary Care @ Kulak, KU Leuven campus Kulak, Etienne Sabbelaan 53, 8500, Kortrijk, Belgium., Beels L; Department of Nuclear Medicine, AZ Groeninge, President Kennedylaan 4, 8500, Kortrijk, Belgium., Maes A; Department of Nuclear Medicine, AZ Groeninge, President Kennedylaan 4, 8500, Kortrijk, Belgium., Van de Wiele C; Department of Nuclear Medicine, AZ Groeninge, President Kennedylaan 4, 8500, Kortrijk, Belgium., Pottel H; Department of Public Health and Primary Care @ Kulak, KU Leuven campus Kulak, Etienne Sabbelaan 53, 8500, Kortrijk, Belgium. hans.pottel@kuleuven-kulak.be.

Publikováno v: EJNMMI physics [EJNMMI Phys] 2018 Dec 07; Vol. 5 (1), pp. 35. Date of Electronic Publication: 2018 Dec 07.